AzTrials
AzTrials

TinnitusNCT00235807

Multi-Site Randomized Clinical Study of Tinnitus Treatment Methods

A study testing Tinnitus Masking, Tinnitus Retraining Therapy (TRT) and Tinnitus Education (TED) in people with Tinnitus, run by US Department of Veterans Affairs at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this multi-site randomized clinical study was to assess treatment outcomes for three forms of tinnitus treatment: Tinnitus Retraining Therapy (TRT), Tinnitus Masking, and Tinnitus Education (TED). Read more about this study

Who is it for?
Ages 21 to 80 years
Conditions the study is for
Tinnitus
What is being tested?
Tinnitus Masking, Tinnitus Retraining Therapy (TRT) and Tinnitus Education (TED)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
144 participants
Where
1 siteUnited States
Study dates
Jun 2004to Nov 2006
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Veterans with a) clinically significant tinnitus, and b) no significant language barrier.

Who cannot join

  • Any medical conditions that would interfere with study participation (e.g., medically or surgically treatable otologic disease; end-stage renal, pulmonary, or cardiovascular disease; patients undergoing chemotherapy or radiation treatment; and patients with severe psychiatric disorders). Subjects must be free from such conditions and will be required to: (1) be between the ages of 2180; and (2) have a weighted error score of 10 or less on the Blessed Orientation-Memory Concentration Test.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA Medical Center, Portland

    Portland, Oregon, 97201

Other trials in United States

About this study

The purpose of this multi-site randomized clinical study was to assess treatment outcomes for three forms of tinnitus treatment: Tinnitus Retraining Therapy (TRT), Tinnitus Masking, and Tinnitus Education (TED). There were four study sites: VAMC Audiology Clinics at Bay Pines, FL; Portland, OR; Seattle, WA; and San Diego, CA. Thirty-six subjects (Veterans) were enrolled into treatment at each site - 12 into each treatment group. Each subject received 18 months of treatment. Treatment appointments and outcome questionnaires occurred at 0, 3, 6, 12, and 18 months. Qualified subjects were initially randomized to one of the treatment groups or to a 6-month Waiting List group. Those in the Waiting List group completed outcome questionnaires at 3 and 6 months, and were randomized into one of the three treatment groups. They then received 18 months of treatment as above.

Read the detailed description

Although tinnitus is especially problematic for Veterans, the DVA has no established protocol for tinnitus rehabilitation. We recently completed a randomized clinical trial to evaluate the efficacy of tinnitus treatment for veterans. Tinnitus Masking and Tinnitus Retraining Therapy (TRT) were both shown to be effective for the majority of Veterans treated with these methods by expert tinnitus clinicians. The objective of the present study was to determine if the same level of treatment efficacy observed in the previous study could be obtained by typical VA audiologists in their clinical environment. In addition, a third group was added, called Tinnitus Education (TED), which served as a control group for nonspecific effects of treatment using a standardized protocol of hearing aids and education.

Veterans with clinically significant tinnitus were recruited to receive treatment with Masking, TRT, or TED in Audiology Clinics at the Bay Pines, Portland, San Diego, and Seattle VAMCs. There were three Treatment Audiologists at each of the sites, one for each of the three treatment methods. Each method uses a variation of sound therapy and of educational counseling. Sound therapy involves the use of wearable ear-level devices, including sound generators (maskers), hearing aids, or combination devices (hearing aid and masker combined). Only the TED group was restricted to the use of hearing aids only (note: TED subjects who did not require hearing aids were the only subjects in this study who did not receive ear-level devices). TRT uses a structured counseling protocol that teaches concepts that are unique to TRT. The Masking protocol has been created to match the TRT counseling with respect to comparable formatting and length of counseling sessions, but containing information specific to the concepts of Masking. The TED counseling protocol is similarly matched in format and length, but the information conveyed is of a more generic nature (general audiologic counseling information). Assessment of outcomes utilized questionnaires that were administered at intervals before, during, and after the 18 months of treatment.

Potential participants at all sites were telephone-screened by the Project Audiologist in Portland to determine if the tinnitus is a clinically significant problem warranting 18 months of treatment. Veterans who passed the screening were scheduled to meet with the Research Coordinator (RC) at the respective study site. At this first visit, Veterans were consented, completed questionnaires, and were then informed as to their group placement. Per a randomization schedule, they were placed into one of the three treatment groups, or into the 6-month waiting list group (with treatment starting 6 months later). At the initial evaluation with the respective Treatment Audiologist, a tinnitus verbal interview was administered, hearing and tinnitus testing were performed, and ear mold impressions were taken to order the custom ear-level devices. The Veteran returned approximately 3-4 weeks later to be fitted with the devices and to receive the counseling/education that initiates treatment. Subjects returned for follow-up treatment at 3, 6, 12 and 18 months. At the follow-up appointments, the RC collected and checked the questionnaires, and the Treatment Audiologist administered the follow-up verbal interview and repeated the counseling protocol.

Conditions
Tinnitus
Being tested
Tinnitus Masking, Tinnitus Retraining Therapy (TRT), Tinnitus Education (TED)
Keywords
Audiology, Rehabilitation, Tinnitus
Medical subject headings
Tinnitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tinnitus MaskingProcedure or surgery

    Sound therapy with Tinnitus Masking is intended to produce immediate relief from the discomfort caused by tinnitus (Vernon, 1977; 1987; Vernon, 1988). If maskers or combination units are used, the masking sound can be set at any level the patient chooses to attain maximum relief. Relief using masking noise can be accomplished using the external sound of the masker, which is generally a more acceptable sound than the tinnitus.

  • Tinnitus Retraining Therapy (TRT)Procedure or surgery

    The TRT procedure adheres as closely as possible to the methodology described by Dr. Pawel Jastreboff. For TRT, sound therapy is used to facilitate long-term habituation to tinnitus (Jastreboff, 1999b).

  • Tinnitus Education (TED)Procedure or surgery

    TED represents tinnitus treatment that would typically be provided by audiologists using hearing aids and counseling (although for this study the counseling has been structured and expanded to be equivalent in length to the other two groups).

Study groups in NCT00235807
Study groupRoleWhat they receive
1Othershould contain an explanation of the nature of the study group (e.g., those with a condition and those without a condition; those with an exposure and those without an exposure).
Receives: Procedure: Tinnitus Masking
2Othershould contain an explanation of the nature of the study group (e.g., those with a condition and those without a condition; those with an exposure and those without an exposure).
Receives: Procedure: Tinnitus Retraining Therapy (TRT)
3Othershould contain an explanation of the nature of the study group (e.g., those with a condition and those without a condition; those with an exposure and those without an exposure).
Receives: Procedure: Tinnitus Education (TED)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Tinnitus Handicap Inventory (THI)

    Measured: Baseline, 3 months, 6 months, 12 months, 18 months

Secondary outcomes (1)
  1. Tinnitus Severity Index (TSI)

    Measured: Baseline, 3 months, 6 months, 12 months, 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2005 (estimated)
  2. Study startJun 2004
  3. Primary completionNov 2006
  4. Study completionNov 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
144 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00235807
Sponsor's protocol ID
C3214R
Status last verified
Mar 2011
First submitted
6 Oct 2005
Last updated
24 Mar 2011
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Tinnitus Masking, Tinnitus Retraining Therapy (TRT) and Tinnitus Education (TED) in people with Tinnitus, run by US Department of Veterans Affairs at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Mar 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Tinnitus Handicap Inventory (THI) (time frame: Baseline, 3 months, 6 months, 12 months, 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in